Evommune, Inc. Common Stock (EVMN)

EBITDA

-$100.36M

TTM · Period ending: · USD

EVMN logo

EVMN EBITDA

Latest reported-$100.36M
EVMN TTM EBITDA (-$63.70M → -$100.36M)
High-resolution chart · PNG

EVMN ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Evommune, Inc. Common Stock EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
-100,355,000
-79,199,000
-69,770,000
-58,341,000
-61,510,000
-75,371,000
-63,697,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.